Background: Risk prediction for myocardial infarction currently uses global risk assessment tools (PROCAM, SCORE or NCEP III). Their sensitivity is however low (about 33%). Emerging risk assessment tools are increasingly applied, but the incremental value is debated.
Background
Traditionally,t he identification of high risk subjects has been based on single cardiovascular risk factors. More recently,the aggregation of these risk factors into global risk calculators, e.g., the PROCAM SCORE [1], the EU SCORE [2] or the NCEP III /A TP III risk calculator [3] has been recommended. Unfortunately these risk calculators tend to have alow sensitivity and may miss up to two thirds of subjects who will experience avascular event during the next ten years, if current thresholds defining ahigh coronary risk are used [1] . Thus there is aneed for new risk stratification tools that can identify high risk subjects otherwise missed by global risk charts. These new or emerging risk stratification tools should however add significant and clinically meaningful information over and above the knowledge derived from risk charts. Several new tests for cardiovascular risk have been proposed, e.g., hsCRP [4] , coronary calcium scoring [5] or carotid intima-tomedia thickness (IMT [6] ). These tests should however be tested themselves for their performance in predicting risk over and above risk derived from risk charts. Basically there are three ways to test atest: cstatistics and receiver operating characteristic curve (ROC) analysis [7] , relative risks and odds ratios (ODDS [8] ), and post-test risk calculation based on Bayes theorem [9] . While some feel that ROC analysis is too hard for anew test to pass [8] , others find relative risk ratios to be atoo easy test to pass. From an epidemiological perspective it is often argued that relative risks below 2.0 have low clinical relevance, but relative risks between 1.2-2.0 are often statistically significant.
In this paper we apply the third approach to testing anew test. We use the principle of sequential testing, where the information from an accepted first test (e.g., risk charts) is used as the pretest probability and posttest risk is calculated usingBayes theorem and involvingthe sensitivity and specificity of the new,additionaltest. Further,inorder to obtain an impression of the ability of TPA-PTP to reclassify subjects correctly into higher or lower risk categories, we performed a "net reclassification improvement" analysis [11] .
Methods

Patients
The patients for the London cohort were being followed up in the Premature Atherosclerosis Clinic and the Stroke Prevention Clinic of the University Campus of the London Health Sciences Center (London, Canada). The original London cohort consisted of 1686 subjects who were followed up for up to five years (mean, 2.5 ± 1.3 years [10] ). From this cohort all subjects with known vascular disease, diabetes mellitus or missing laboratory values affecting the calculation of NCEP IIIbased risk were excluded (N =1 002, table 1). The follow-up time for the non-excluded subjects (N =6 84) was 3.3 ±1.8 years.
Clinical and laboratory measurements
Blood lipids were measured after a1 2-hour fast from whole blood samples using routine methods in the biochemistry laboratory of the London Health Science Center.Blood pressure was recorded in the sitting position using an automated device (DINAMAPP).
Risk assessment using NCEP III risk algorithm and outcome data
For each subject, NCEP III-based 10-year risk for myocardialinfarction was calculated online (http://hp2010. nhlbihin.net/atpiii/calculator.asp?usertype=prof). The occurrence of myocardial infarction was either fatal or non-fatal and was assessed by death certificates or review of hospital records.
Imaging method and risk assessment using total plaque area of carotid arteries.
TPAisam easure of the total plaque burden found in both carotid arteries. Plaques are traced longitudinally, and the TPAisd erived as the sum of all plaque areas detected during the imaging of both carotid arteries. (Example of alongitudinal plaque tracing: fig. 1 ). TPA showed an intraobserver and interobserver reliability (intraclass correlation) of K=0.94 and K=0.85 respectively [10] . The cutoff of the TPAtest for being positive was set at ≥0.18 cm 2 .TPA 0.18-0.55 cm 2 is the amount of TPAo ft he third quartile of the group observed (N =684), TPA0.56-4.83 cm 2 is the 4th quartile. There waso nly one AMI in the 1st and 2nd quartile, so the use of our cutoff for positivityappears justified.
Statistical methods
We use the principle of sequential testing, where the information from an accepted first test (e.g., risk charts) is used as the pretest probability and posttest risk is calculated using Bayes theorem and involving the sensitivity and specificity of the new,a dditional test. We apply this approach to aprevention clinic setting, where acohort of 684 originally healthy subjects from the London cohort [10] suffered 13 myocardial infarctions during af ollow-up of 3.3 years. All subjects were tested with NCEP III risk charts (3) and with the total plaque area (TPA), am easure of carotid plaque burden. TPAposttest probabilities (TPA-PTP) were calculated. Remaining primary caresubjects 684 41
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Figure1
Example of aplaque area measurement.
Data were compiled in aM icrosoft ® Office Excel data sheet (Microsoft, Redmond, WA,USA) and further analysed with Analyze-it TM ,Ltd, version 2.03. Posttest probabilities were calculated as follows: for each patient ap retest probability was calculated from NCEP III, which gave the 10-year risk for myocardial infarction in percent. Results of atherosclerosis imaging (TPA) were used to assess the level of sensitivity and specificity of these tests according to ROC curves for NCEP III, TPA, TPA-PTP were compared using the DeLong method for comparison of ROC curves [13] . Further,weused Net Reclassification Improvement to assess the clinical relevance of TPA posttest probability to reclassify subjects. For this purposew ec ounted in subjects with an event during follow-up ar eclassification from al ower to ah igher risk category (defined as 0-9.99% =l ow risk, 10-19.99% = intermediate risk, 20.00% and more =high risk) as +1, ar eclassification from higher to lower risk as -1 and no reclassification as 0. Similarly, in subjects without an event, correct reclassification to al ower risk category using TPAposttest probability was counted as +1, upward reclassification into ah igher risk category as -1 and no reclassification as 0.
For statistical analysis the level of significance was set at p<0.05.
Results
Patients
684 primary prevention subjects were available for further risk assessment (table 3) . In this group of primary prevention subjects, mean age was 50 ±1 3y ears and 50% were females; 38% were smokers and 52% had a history of hypertension. Mean follow-up ±standard deviation was 3.3 ±1.8 years. Atotal of 13 myocardial infarctions occurred during follow-up. The NCEP III estimate for ten-year myocardial infarction incidence was 7%, the average total carotid plaque was 0.48 cm 2 ±0 .76 cm 2 and the posttest risk estimate for 10-year myocardial infarction incidence was 10%. The observed myocardial infarction incidence extrapolated to ten years was 6% for the entire primary care group.
Sensitivities and specificities of NCEP III, TPAand TPA-PTP
Using acutoff of ≥20% ten-year risk for myocardial infarction, the sensitivity and specificity of NCEP III to detect 13 myocardial infarctions in 684 subjects followed up for an average of over 3.3 years was 31% and 89%, and was 39% and 79% for TPA-PTP respectively (p NS for all comparisons).
The sensitivities and specificities for various severities of TPAserved to calculate posttest probabilities (TPA-PTP) and are outlined in table 2. For lower TPA values, sensitivity was 92% at the cost of specificity (25%), whereas in subjects with ah igher TPA(>0.55 cm 2 ), specificity increased to 75% at the cost of sensitivity (62%).
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Net reclassification improvement
In the 13 subjects with events, TPAposttest probability correctly shifted four subjects into ahigher risk category and none into al ower risk category,a nd thus 30.77% of subjects with events were correctly reclassified. In 671 subjects without an event, 130 were incorrectly shifted into ahigher risk group, 495 subjects remained in thes ame risk group and 46 subjects were correctly classified into al ower risk group. Thus 84 of 671 subjects with no events were incorrectly reclassified (12.52%). This implies an et reclassification improvement of 18.25%.
Discussion
Primary prevention of atherothrombosis leading to myocardial infarction is difficult because of the low sensitivities of coronary risk charts [2] . Coronary risk charts are based on major independent cardiovascular risk factors such as age, sex, hypertension, cholesterol and smoking, whereas diabetes mellitus is frequently regarded as ah igh risk category per se [1-3]. When excludingdiabetes from risk calculations, the area under the curve (AUC) of risk charts remains modest, usually within arange between 0.65 and 0.75 [1-3]. Several additional tools have been proposed as coronary risk modifiers in order to reclassify subjects and identify high risk conditions earlier.However,most of such emerging risk factors failed to give additional diagnostic information in ROC analysis [4, 6] , with the exception of coronary calcium scores [5] . However,w hen relative risk and odds ratios are used after correction for major independent cardiovascular risk factors, statistically significant improvements in risk prediction could be observed [8] . This is, for example, the case of high sensitivity C-reactive protein [8] or ac luster of genetic tests [12] . In this study we performed as tatistical analysis of the additional value of TPAusing posttest risk calculation, comparison of ROC curves and net reclassification improvement, as discussed elsewhere [14] .
In our study we aimed to introduce an alternative risk assessment strategy that incorporates calculation of posterior probabilities before performing an ROC comparison; thus we partially circumvent the debate on the clinical value of ROC analysis and odds ratios. We exemplified this strategy in arelatively young primary care cohort of 684 patients with am ean age of 50 years and amean follow-up time of 3.3 years and in whom 13 myocardial infarctions occurred. These 684 patients were part of the London cohort [10] . In each patient, NCEP III risk could be assessed and posterior test probabilities (PTP) could be calculated using the total plaque area (TPA) of both carotid arteries as asequential test. We found that the area under the curve (AUC) could be significantly improved from 0.68 for NCEP III to 0.75 for TPA-PTP (p =0.0034). Therefore, TPAcombined with NCEP III by using posterior test probabilities allowed for asignificantly better prognosis than NCEP III alone or TPAalone when c-statistics were used [13] . Thus TPA-PTP may be used as a sequential test in primary care subjects in whom the Cardiovascular Medicine 2011;14(2):53-57
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Limitations
The gold standard of this study,which is myocardial infarction occurrence during follow-up, was only measured duringa na verage observation time of 3.3 ±1 .8 years and had to be extrapolated to aten-year risk for our test performance calculations. However,since risk tends to increase linearly at least until the age of 60, use of linear extrapolation may be justified in our relatively young cohort of subjects with an average age of 50 years at entry into observation. Another matter of concern is the small number of events (N =1 3) during follow-up in our cohort. However,despite this limitation, we were able to show asignificant improvement in the c-statistics using posterior probabilities based on the Bayes theorem. Hence this statistical model may be used to assess the utility of new and emerging tests in clinical practice. Certainly our approach deserves further testing and external validationinlarger cohorts with more frequent occurrence of endpoints.
Conclusions
The concept of sequential testing and calculation of posterior probabilities is appealing because it uses a scientifically accepted measure of coronary risk (e.g., ten-year risk for myocardial infarction based upon risk algorithms such as PROCAM, SCORE or NCEP III) as ap retest probability and permits calculation of absolute posttest coronary risk based on posttest risk calculation. Despitet he small number of myocardial infarctions in our study cohort,T PA-PTP achieved a significant improvement in AUC over NEP III alone, which was not the case of TPAalone. Statistically significant improvement in c-statistics in sequential testing may be obtained by applying posttest risk probabilities to the pretest probability.Further,wewere able to show that with this approach ac linically relevant reclassification improvement can be obtained. Our approach represents aconservative estimate of the value of emerging tests in preventive medicine; however, cost-effectiveness of these posttest-risk calculations remains to be elucidated.
Finally,T PA used in relatively young subjects yielded excellent predictive results in our study.Itmay therefore be used instead of coronary calcium testing with its inherent radiation risk. It may help to riskstratify subjects better at an earlier stage, where coronary risk interventions are more likely to improve outcome, especially in relatively young healthy subjects where risk-lowering strategies are most likely to improve long-term outcome.
